<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02238730</url>
  </required_header>
  <id_info>
    <org_study_id>KPSC IRB10133</org_study_id>
    <secondary_id>KPSC IRB 10133</secondary_id>
    <nct_id>NCT02238730</nct_id>
  </id_info>
  <brief_title>Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy</brief_title>
  <official_title>Comparative Efficacy and Cognitive Side-Effects of Ultrabrief Right Unilateral Electroconvulsive Therapy and Brief Pulse Bitemporal Electroconvulsive Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the equivalent efficacy of ultrabrief pulsewidth right unilateral
      electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy in the
      treatment of depression and to evaluate the cognitive effects of ultrabrief right unilateral
      electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized to either bitemporal brief pulse electroconvulsive therapy ( 0.5
      ms pulse width) or right unilateral ultrabrief pulse electroconvulsive therapy for the first
      six treatments. If further treatment is necessary, electrode placement will be chosen by the
      treating psychiatrist. All electroconvulsive therapy treatments will be performed with a
      Thymatron System IV instrument. (Somatics, LLC, Lake Bluff, Illinois, USA) Pre-
      electroconvulsive therapy testing will occur within one week of beginning treatment.
      Post-electroconvulsive therapy testing will occur within 48 hours of the 6th treatment.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Resources not available for the study
  </why_stopped>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">February 15, 2017</completion_date>
  <primary_completion_date type="Actual">February 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Depression Rating Scale (HAMD)</measure>
    <time_frame>up to 2-3 weeks</time_frame>
    <description>Standardized assessment administered by a psychologist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mini Mental Status Examination</measure>
    <time_frame>up to 2-3 weeks</time_frame>
    <description>Standardized assessment administered by a psychologist</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Depression</condition>
  <condition>Depressive Disorder</condition>
  <condition>Treatment Resistant Depressive Disorder</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Ultrabrief Right Unilateral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrabrief (0.25 ms) Right Unilateral Electroconvulsive Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brief Pulse Bitemporal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brief Pulse (0.5 ms) Bitemporal Electroconvulsive Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrabrief Right Unilateral</intervention_name>
    <description>The first six electroconvulsive therapy sessions using ultrabrief (0.25 ms) right unilateral electroconvulsive therapy</description>
    <arm_group_label>Ultrabrief Right Unilateral</arm_group_label>
    <other_name>Thymatron System IV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Brief Pulse Bitemporal</intervention_name>
    <description>The first six electroconvulsive therapy sessions using brief pulse (0.5 ms) bitemporal electroconvulsive therapy</description>
    <arm_group_label>Brief Pulse Bitemporal</arm_group_label>
    <other_name>Thymatron System IV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients age 18 and above referred for electroconvulsive therapy will be screened
             for eligibility for participation in this study.

          -  Basic competency in English

          -  Diagnosis of either of the following:

               1. Major Depressive Disorder, Single Episode

               2. Major Depressive Disorder, Recurrent

               3. Bipolar Disorder, Currently Depressed

        Exclusion Criteria:

          -  Pre-existing cognitive impairment with an initial Mini Mental Status Exam Score of 24
             or lower

          -  Major neurological disease

          -  Other medical conditions making electroconvulsive therapy an excessive risk to be
             completed safely in an outpatient surgery center and anticonvulsant therapy.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronad L Warnell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2014</study_first_submitted>
  <study_first_submitted_qc>September 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2014</study_first_posted>
  <last_update_submitted>February 15, 2017</last_update_submitted>
  <last_update_submitted_qc>February 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Depressive Disorder</keyword>
  <keyword>Treatment Resistant Depressive Disorder</keyword>
  <keyword>Bipolar Disorder</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Electroconvulsive therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

